What is HYPD's market cap?

$46.67M, based on the Nov 4 close of $3.07.

Does Hyperion DeFi pay a dividend?

No regular cash dividend has been paid in the last year.

How much of HYPD is sold short?

1.3M shares, 9.0% of float, as of Oct 15, 2026.

What sector is HYPD in?

Healthcare, in the Pharmaceuticals industry.

NASDAQ · HYPDHealthcarePharmaceuticals

Hyperion DeFi, Inc. Common Stock (HYPD)

$3.07+0.66%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$3.07▼ 43.31% in range

Nov 4, 2025Low $2.34 · High $6.44Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Hyperion DeFi closed at $3.07 on Nov 4, up 0.66%, 52.3% below its 52-week closing high. Volume of 99.8K shares was 0.37× its 20-day average (below normal).

Split-adjusted performance: -19.6% over one month, -15.7% over six months, -48.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $357.69K, with a net margin of 4009.1%.

Short interest was 1.3M shares at the Oct 15 settlement, up 14.6% from the prior report (9.0% of float, 3.7 days to cover).

Market cap$46.7M15.2M shares

Revenue · quarter$357.7K—

Diluted EPS$0.92—

P/E · TTM—P/S 33.3×

Net margin4,009.1%Gross 100.0%

Dividend yieldNone

52-week range2.34 – 6.44−52.3% from high

Volume99.8K0.37× 20-day avg

Volatility · 60d89.8%Annualised

Short % of float9.0%3.7 days to cover

Net cash$1.2MCash $9.6M

Next earnings—Not scheduled

Split-adjusted performance

1W +2.3%1M −19.6%3M +15.0%6M −15.7%YTD −13.8%1Y −48.1%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum60

Revenue growth—

Net margin100

Value (low P/E)—

Size29

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short1.3M+14.6% vs prior

Days to cover3.7Settled Oct 15

% of float9.0%

Short vol. 10d48.2%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
HYPDHyperion DeFi	$3.07	+0.66%	−15.7%	—	4009.1%	—	$46.7M
INMInMed Pharmaceuticals	$8.75	+420.83%	+1104.6%	—	—	—	$48.1M	Compare
GANXGain Therapeutics	$1.11	−3.48%	−41.9%	—	—	—	$48.4M	Compare
BMEABiomea Fusion	$0.6119	−1.91%	−61.8%	—	—	—	$44.4M	Compare
ATNMActinium Pharmaceuticals	$1.41	+0.71%	+13.7%	—	79.7%	3.9	$44.3M	Compare
CNTBConnect Biopharma Holdings Limited	$0.7805	+0.83%	−68.5%	+5666.7%	−624.4%	—	$49.2M	Compare
SERSerina Therapeutics	$1.69	−7.65%	−7.7%	−100.0%	—	—	$42.9M	Compare
IBIOiBio	$0.8000	−2.85%	−54.8%	−100.0%	—	—	$51.4M	Compare
ELTXElicio Therapeutics	$1.56	+2.63%	−85.1%	—	—	—	$42.3M	Compare

News about Hyperion DeFi

All news →

Hyperion DeFi Announces Participation in Upcoming Investor and Industry ConferencesGlobeNewswire Inc. · Apr 27, 2026▲ Positive

Quick answers

What does Hyperion DeFi do?: Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest-growing and highest-revenue-generating blockchains in the world.
What is HYPD's market cap?: $46.67M, based on the Nov 4 close of $3.07.
Does Hyperion DeFi pay a dividend?: No regular cash dividend has been paid in the last year.
How much of HYPD is sold short?: 1.3M shares, 9.0% of float, as of Oct 15, 2026.
What sector is HYPD in?: Healthcare, in the Pharmaceuticals industry.

About Hyperion DeFi

Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest-growing and highest-revenue-generating blockchains in the world. Shareholders benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its on-chain utility. It is working to provide its shareholders with simplified exposure to the Hyperliquid ecosystem, which is believed to be among the highest-revenue-generating blockchains in the world, according to information from various blockchain data tracking sources, including Artemis Analytics and DefiLlama.

HQ: Dallas, TX9 employeesListed Jan 25, 2018hyperiondefi.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology